The technology, according to the release, targets tumors more precisely and allows for adjustments to be made before each treatment, tailored to a patient’s individual needs.
“Due to the personalized nature of adaptive radiotherapy, a clinician may be able to deliver even higher doses of radiation to the cancer while sparing healthy organs and cells,” the news release states.
In addition, treatments with the technology can be completed in normal radiation time slots.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.